Mertiva AB, formerly Diamyd Medical AB, is a Sweden-based company active within the healthcare sector. As of August 31, 2013, the Company owned 8% shares of the United-States based Protein Sciences Corporation, as well as 19% shares of Mercodia AB. The Company changed its name in May 2013. Additionally, its subsidiary, Diamyd Therapeutics, was spun off and changed its name to Diamyd Medical.

Employees

Sector

Biotechnology & Medical Research

More about the company

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Market Cap	772M 677M 623M 578M 1.1B 73.69B 1.11B 7.46B 2.9B 36.17B 2.9B 2.84B 125B	P/E 2018	28.3x	P/E 2019	13.3x
Enterprise Value	689M 604M 556M 516M 980M 65.76B 994M 6.66B 2.59B 32.28B 2.59B 2.53B 112B	EV / Sales 2018	-	EV / Sales 2019	-
Free-Float	68.13%	Yield 2018 *	-	Yield 2019	-

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI
11/07/17	Sanofi Pasteur Inc. agreed to acquire Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others for $750 million	CI
29/11/15	Mertiva AB's Equity Buyback announced on December 6, 2012, has expired.	CI
18/12/14	Mertiva AB (OTCPK:DMYD.F) acquired an additional 0.54% stake in Protein Sciences Corporation for $0.62 million.	CI
22/01/14	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
11/10/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
08/10/13	The members of the management of Diamyd, Inc. cancelled the acquisition of 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B).	CI
25/09/13	Mertiva AB (OTCPK:DMYD.F) acquired an additional 7.27% stake in Protein Sciences Corporation from Pacific Rim Ventures Co., Ltd. and other shareholders for $8.4 million.	CI
27/08/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic All-Share Index	CI
30/07/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic Small Cap Index	CI
04/07/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
23/04/13	Diamyd Medical AB Announces Board Appointments	CI

Date	Insider	Type	Main position	Quantity	% Market Cap.
14/10/20	Sven Håkan Blomdahl	Buy	Chairman	24,314	0.1775%
08/10/20	Sven Håkan Blomdahl	Buy	Chairman	5,378	0.0393%
08/10/20	Sven Håkan Blomdahl	Buy	Chairman	6,321	0.0461%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MERTIVA AB	-	0.00%	-	-	89.46M
LONZA GROUP AG	+1.08%	+7.56%	+4.01%	+9.84%	49.92B
REVOLUTION MEDICINES, INC.	-0.12%	-1.74%	+416.12%	+622.37%	40.23B
IQVIA HOLDINGS INC.	-0.18%	+6.90%	+27.18%	-5.07%	34.55B
BEONE MEDICINES AG	+4.02%	+6.92%	+28.66%	+63.68%	33.09B
CELLTRION, INC.	-4.19%	+6.03%	+3.76%	+32.17%	27.51B
ASCENDIS PHARMA A/S	-1.54%	+2.48%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+0.39%	+4.59%	+75.38%	+139.03%	15.92B
EUROFINS SCIENTIFIC SE	-0.95%	+0.76%	+13.97%	+21.59%	13.86B
IONIS PHARMACEUTICALS, INC.	+2.21%	+3.63%	+100.14%	+100.24%	13.52B
Average	+0.04%	+5.72%	+83.65%	+122.98%	24.58B
Weighted average by Cap.	+0.13%	+6.43%	+94.84%	+140.92%

Mertiva AB Stock

Stocks

MERT A

SE0010023432

Biotechnology & Medical Research

Valuation: Mertiva AB

Latest news : Mertiva AB

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

End-of-day quote NORDIC GROWTH MARKET Other stock markets
- ^SEK	-

	2018	2019
Net sales	-	-
Net income	25.3M 22.16M 20.41M 18.94M 35.97M 2.41B 36.46M 244M 95.07M 1.18B 95.01M 92.92M 4.11B	76.99M 67.43M 62.11M 57.65M 109M 7.34B 111M 743M 289M 3.6B 289M 283M 12.5B
Net Debt	-253M -221M -204M -189M -360M -24.12B -364M -2.44B -950M -11.84B -950M -929M -41.05B	-83.08M -72.76M -67.01M -62.2M -118M -7.92B -120M -802M -312M -3.89B -312M -305M -13.49B